March 03, 2015 4:07 PM ET


Company Overview of Helix Therapeutics, Inc.

Company Overview

Helix Therapeutics, Inc. develops deoxyribonucleic acid (DNA) based therapeutics. It develops novel sequence-specific gene-targeting reagents for the treatment of HIV/AIDS and common genetic diseases, such as sickle cell anemia, thalassemia, and cystic fibrosis. The company was founded in 2006 and is based in New Haven, Connecticut.

150 Munson Street

25 Science Park

New Haven, CT 06511

United States

Founded in 2006



Key Executives for Helix Therapeutics, Inc.

Chief Executive Officer and President
Co-Founder and Director
Co-Founder and Director
Age: 71
Co-Founder and Director
Age: 53
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Synthecon, Inc. United States
International Immuno Diagnostics Inc. United States
Cogenics Icoria, Inc. United States
Fluoresentric, Inc. United States
Igx Corp DE United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Helix Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at